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Abstract
Microarray analysis of Pseudomonas aeruginosa mRNA transcripts expressed in vivo during animal infection has not been
previously used to investigate potential virulence factors needed in this setting. We compared mRNA expression in bacterial
cells recovered from the gastrointestinal (GI) tracts of P. aeruginosa-colonized mice to that of P. aeruginosa in the drinking
water used to colonize the mice. Genes associated with biofilm formation and type III secretion (T3SS) had markedly
increased expression in the GI tract. A non-redundant transposon library in P. aeruginosa strain PA14 was used to test
mutants in genes identified as having increased transcription during in vivo colonization. All of the Tn-library mutants in
biofilm-associated genes had an attenuated ability to form biofilms in vitro, but there were no significant differences in GI
colonization and dissemination between these mutants and WT P. aeruginosa PA14. To evaluate T3SS factors, we tested GI
colonization and neutropenia-induced dissemination of both deletional (PAO1 and PAK) and insertional (PA14) mutants in
four genes in the P. aeruginosa T3SS, exoS or exoU, exoT, and popB. There were no significant differences in GI colonization
among these mutant strains and their WT counterparts, whereas rates of survival following dissemination were significantly
decreased in mice infected by the T3SS mutant strains. However, there was a variable, strain-dependent effect on overall
survival between parental and T3SS mutants. Thus, increased transcription of genes during in vivo murine GI colonization is
not predictive of an essential role for the gene product in either colonization or overall survival following induction of
neutropenia.
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Introduction
Modern molecular tools allow for analysis of levels of mRNA in
bacterial cells living in different environments and many such
studies have been applied to Pseudomonas aeruginosa [1,2,3,4,5].
However, apart from one study analyzing mRNA expression in P.
aeruginosa present in the sputum of a single cystic fibrosis patient [6],
no other studies have analyzed P. aeruginosa gene expression during
in vivo infection. Part of the problem lies with recovering sufficient
mRNA from bacterial cells directly isolated from infected tissues for
microarray analysis. In a previously described model of murine GI
colonization and dissemination following induction of neutropenia
[7] we found that high levels of P. aeruginosa could be recovered from
the mouse cecum, potentially identifying a source of in vivo bacterial
mRNA sufficient for microarray analysis. This model mimics the
morbidity and mortality of immunocompromised hosts such as
patients with leukemia, severe burn wounds or recipients of organ
transplants[8].Inmanypatients at-riskforP.aeruginosainfection(i.e.
surgical patients, cancer patients receiving chemotherapy) the
gastrointestinal (GI) tract is believed to be the main tissue initially
colonized by this organism, often times allowing for translocation to
extra-gastrointestinal sites and, in the worst cases, development of
life-threatening sepsis [9,10]. In this patient group, P. aeruginosa has
the highest case-fatality rate among all gram-negative pathogens
[11].The merepresence ofP. aeruginosa intheGItract ofcritically-ill
surgical patients is associated with a 70% mortality rate, a three-fold
increase over physiologically matched critically-ill patients not
infected with P. aeruginosa [12].
Here we report that enough in vivo-expressed P. aeruginosa
mRNA can be recovered from microbial cells in the cecum of
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bacterial phenotypes thought to be important in virulence,
production of biofilms and elaboration of type III secretion system
(T3SS) effectors, had consistent increases in mRNA levels when
compared with expression levels in the bacteria living in the water
used to colonize the mice. Using P. aeruginosa strains from both a
non-redundant transposon insert library in strain PA14 [13] as
well as deletional mutants in strains PAK and PA01, we confirmed
that the genes with increased transcription that were involved
biofilm production were deficient in this phenotype in vitro, but
were not compromised in either their ability to colonize the GI
tract in vivo or disseminate following induction of neutropenia.
Mutants in T3SS effector genes were also not deficient for GI
colonization. Mice infected with these mutants had an increase in
time of survival after induction of neutropenia but variable, strain-
dependent effects on overall mouse survival with different T3SS
mutants. Our findings validate a system for measuring gene
expression of P. aeruginosa during an important phase of the
pathogenesis of human disease, but also indicate that increased
mRNA expression is not necessarily predictive of a phenotype
needed by this organism to induce or maintain in vivo infection or
cause WT levels of pathology.
Results
Transcription Profiling of P. aeruginosa in the Murine GI
Tract
We initially identified P. aeruginosa genes that were differentially
transcribed in the GI tract of eight colonized C3H mice in
comparison to genes expressed in sterile water containing 1500 U
penicillin G/mL. For both the basal state and colonization states,
three separate biologic replicates were performed. We chose to use
P. aeruginosa recovered from the drinking water as the baseline
condition since water contaminated with P.aeruginosa is often cited
as the source for both nosocomial and community-acquired P.
aeruginosa infections. Within the hospital, P. aeruginosa is most often
isolated from water sources such as sinks, drains, toilets, and
showers [14] and has been identified by molecular techniques (e.g.
genotyping) to be the causative pathogen in documented P.
aeruginosa infections [15]. Furthermore, community-acquired P.
aeruginosa infections are also often associated with exposure to
contaminated water sources (i.e. swimming pools, hot tubs) [16].
Given the epidemiology of P. aeruginosa acquisition and the fact
that our murine model was designed with the aim of recapitulating
the pathogenesis of P. aeruginosa infection in a human host, we felt
that using bacteria recovered from the drinking water was the best
representative of a baseline condition. Although the P. aeruginosa
arrays were developed using the PAO1 genome [17], previous
studies have shown that the strain PAK transcriptome of the genes
conserved between these two strains can be reliably measured with
P. aeruginosa Genome Arrays (of the 5886 P. aeruginosa probe sets
included on the microarray, 5678 were detected using PAK DNA)
[18]. An average of the microarray hybridization intensity data (3
microarrays) for both baseline (drinking water) and colonization
state (cecums) was generated and compared (Gene Expression
Omnibus Accession Number GSE22665). Statistical analysis of the
derived transcriptomes indicated that 1089 genes (including 321
hypothetical and unclassified genes) showed a two-fold increase in
expression from the baseline to the GI colonization state, and 423
genes (including 229 hypothetical and unclassified genes) showed a
two-fold decrease in expression from baseline (Figure 1).
We found that the transcript levels of genes functionally
classified as being involved in Cell Wall/LPS/Capsule were
generally increased by two-fold or more over expression when the
bacteria are in water: 34 of 86 genes (40%) involved in Cell Wall/
LPS/Capsule function were expressed at a higher level in the GI
tract versus 2 of 86 (2%) genes expressed at a ,2-fold lower level.
In contrast, relatively few genes involved in membrane protein
synthesis were changed (3 of 43 increased versus 7 of 43
decreased), and genes involved in motility and attachment were
roughly evenly increased or decreased (18 of 67 genes had
increased mRNA levels while 20 of 67 genes had decreased
mRNA levels). Of the 16 biofilm genes that we chose to study, 11
of 16 genes (69%) were expressed at .2-fold level in the GI tract
compared to expression levels of bacteria in water. Most
interesting, however, was that 98% of the genes (39 of 40)
involved in the Type III Secretion System had increased
expression and none had decreased expression (Table 1). Of the
5 T3SS genes that we studied, all of the genes (with the exception
of exoU, since exoU is absent in strain PAK) showed a seven-fold or
higher increase in transcript levels (Table 1).
Selection of P. aeruginosa PA14 strains with insertions in
genes needed for biofilm formation
Using the data generated from several studies [19,20,21,22], we
identified genes that have been shown to be important for all
stages of in vitro biofilm formation: fleR, flgK,fliP, sadB, crc, pilB, pilC,
pilY1, PA3782, lasI, rhlA, and rpoN. Next, we cross-referenced the
murine GI colonization transcriptome data that we generated with
three published transcription profiling studies related to P.
aeruginosa biofilm formation in vitro [2,4,5]. Two genes encoding
hypothetical proteins (PA0713 and PA0952) were significantly
increased in 2 or more datasets (Table 2), and two additional genes
encoding hypothetical proteins were found to be important in
biofilm formation using a signature-tagged mutagenesis analysis of
factors needed for virulence in a rat P. aeruginosa pulmonary lung
infection [23] model: PA0141 (25 fold increase) and PA1009 (4.8
fold increase). The transcriptome results generated from murine
GI colonization for genes known to be involved in biofilm
formation in vitro and for the genes encoding hypothetical proteins
are provided in Table 2.
Microtiter Biofilm Assay
We then used a non-redundant transposon mutant library in P.
aeruginosa strain PA14 [13], to retrieve mutant strains with
transposon insertions in the candidate genes identified above
(Table 2). The disruption of the target genes by the transposon was
confirmed bycolonyPCR.Next,themutantsweretested forbiofilm
formation in vitro using a 96-well microtiter plate assay [20] on two
different substrates: polystyrene (PS) and polypropylene (PP).
Several strains (i.e., PA14fliP, fleR and flgK) were attenuated in both
in vitro biofilm formation and growth rates (Figure 2). Assuming a
linear relationship between growth and biofilm formation, biofilm
to growth ratios were calculated to account for differences in growth
(Figure 3).Ratiosless than 1 comparedto that ofthewild-type strain
were designated as indicative of decreased biofilm formation. The
same PA14 mutants (with insertions in pilB, sadB, crc, fleR, pilY1, flgK,
fliP, and pilC genes) that showed significant absolute decreases in
biofilm formation also had biofilm:growth ratios less than 1. (Fig. 3).
We also analyzed biofilm formation by the P. aeruginosa strain
PA14galU
2 which is unable to synthesize a complete outer core
lipopolysaccharide (LPS) [24], as this strain is unable to colonize the
antibiotic-treatedmurineGItract[7].Interestingly,thegalUmutant
had a biofilm:growth ratio of 2.5 on PP, making it a better biofilm
former than the WT strain PA14.
We also tested biofilm formation under anaerobic conditions (to
better approximate conditions found in the human gastrointestinal
tract[25]) on both PP and PS substrates. The 8 mutants (pilB, sadB,
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formation and biofilm/growth ratios when grown anaerobically
as those produced under aerobic growth conditions (data not
shown).
Colonization and Systemic Dissemination from the
Murine GI Tract by Biofilm-deficient TN-mutants
The strains identified as attenuated for biofilm formation in
vitro were further investigated for colonization and dissemination
Figure 1. Functional classification of P. aeruginosa (PAK strain) genes differentially expressed in murine gastrointestinal
colonization. The functional classes are according to the Pseudomonas Community Annotation Project (www.pseudomonas.com). The percentage
of differentially expressed genes is calculated as the number of genes in each class divided by the total number of differentially 26up-regulated or
26down-regulated genes. Note that many genes have more than one functional annotation. LPS, lipopolysaccharide.
doi:10.1371/journal.pone.0015131.g001
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tion model [7]. Wild-type P. aeruginosa PA14 consistently
colonized the mouse GI tract at levels comparable to those
previously reported [7] for P. aeruginosa strain PAO1: PA14 (n=8,
median=3.76610
8 cfu/g stool, first quartile=2.84610
8, third
quartile=5.24610
8) and PAO1 (n=8, median=3.52610
8 cfu/g
stool, first quartile=2.64610
8, third quartile=3.81610
8,F i g .4 ) .
All mutant strains colonized the murine GI tract at comparable
levels to WT P. aeruginosa PA14, with the exception of the
PA14crc- mutant and the negative control strain, PA14galU-,
which does not colonize at detectable levels (Fig. 4). The PA14crc-
mutant did colonize the GI tract but at significantly lower levels
(slightly more than one-log) compared to WT PA14: crc (n=8,
median=2.93610
7 cfu/g stool, first quartile=1.31610
7, third
quartile=3.77610
7; PA14 (n=8, median=3.15610
8 cfu/g
stool, first quartile=3.02610
8,t h i r dq u a r t i l e = 3 . 6 0 610
8,
p=0.0002 by Mann Whitney test compared to PA14Dcrc,
Fig. 4). Confirmation of maintenance of the mutant genotype
was obtained by performing PCR on colonies recovered from
murine feces.
Table 1. Type III Secretion Gene Expression in P. aeruginosa murine GI colonization.
Gene Name Function Fold Activation Mean (SEM)
exoS (PA3841) exoenzyme S 25.5 (3.4)
exoT (PA0044) exoenzyme T 18.9 (0.9)
exoY (PA2191) adenylate cyclase ExoY 7.2 (0.1)
exsA (PA1713) transcriptional regulator ExsA 10.0 (0.6)
exsB (PA1712) exoenzyme S synthesis protein B 3.3 (0.6)
exsC (PA1710) exoenzyme S synthesis protein C precursor 3.1 (0.2)
exsD (PA1714) hypothetical protein 7.1 (1.2)
orf1 (PA3842) probable chaperone 14.4 (1.7)
pcr1 (PA1699) conserved hypothetical protein in type III secretion 19.6 (5.1)
pcr2 (PA1700) conserved hypothetical protein in type III secretion 11.0 (1.8)
pcr3 (PA1701) conserved hypothetical protein in type III secretion 10.7 (1.6)
pcr4 (PA1702) conserved hypothetical protein in type III secretion 13.1 (1.8)
pcrD (PA1703) type III secretory apparatus protein PcrD 8.8 (0.8)
pcrG (PA1705) regulator in type III secretion 3.9 (0.1)
pcrH (PA1707) regulatory protein PcrH 9.5 (0.7)
pcrR (PA1704) transcriptional regulator protein PcrR 2.9 (0.3)
pcrV (PA1706) type III secretion protein PcrV 8.5 (1.2)
PopB (PA1708) translocator protein PopB 8.9 (1.1)
PopD (PA1709) Translocator outer membrane protein PopD precursor 10.1 (1.3)
PopN (PA1698) Type III secretion outer membrane protein PopN 12.7 (2.7)
pscB (PA1715) type III export apparatus protein 16.5 (4.0)
pscC (PA1716) Type III secretion outer membrane protein PscC precursor 10.1 (1.0)
pscD (PA1717) type III export protein PscD 12.8 (2.0)
pscE (PA1718) type III export protein PscE 10.4 (2.5)
pscF (PA1719) type III export protein PscF 16.4 (3.8)
pscG (PA1720) type III export protein PscG 10.9 (1.4)
pscH (PA1721) type III export protein PscH 10.1 (2.0)
pscI (PA1722) type III export protein PscI 7.5 (2.6)
pscJ (PA1723) type III export protein PscJ 8.1 (1.8)
pscK (PA1724) type III export protein PscK 6.3 (0.9)
pscL (PA1725) type III export protein PscL 5.2 (1.5)
pscN (PA1697) ATP synthase in type III secretion system 9.1 (0.4)
pscO (PA1696) translocation protein in type III secretion 15.5 (1.4)
pscP (PA1695) translocation protein in type III secretion 58.8 (2.9)
pscQ (PA1694) translocation protein in type III secretion 9.9 (2.3)
pscR (PA1693) translocation protein in type III secretion 5.7 (0.7)
pscS (PA1692) probable translocation protein in type III 4.0 (0.1)
pscT (PA1691) translocation protein in type III secretion 2.8 (0.7)
PA1711 hypothetical protein 3.6 (0.3)
doi:10.1371/journal.pone.0015131.t001
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Gene Name Function Fold activation (mean, SEM)
This study Hentzer et al. Waite et al. 8 hours*Waite et al. 48 hours*
PA0713 Hypothetical 24.8 (2.0) 2.8 3.4 3.7
PA0952 Hypothetical 15.6 (4.7) 4.2 4.4 2.0
PA0141 Hypothetical 24.8 (0.9) 3.0 0.1 0.8
PA1009 Hypothetical 4.9 (0.1) -------- 1.9 1.0
crc (PA5332) Catabolite repression control protein 1.9 (0.1) ------ 0.4 0.4
fleR (PA1099) Two-component response regulator 0.3 (0.03) ------ 0.7 0.1
flgK (PA1086) Flagellar hook-associated protein 1 3.1 (1.0) ------ 0.6 0.2
fliP (PA1446) Flagellar biosynthetic protein 0.3 (0.02) ------ 0.6 0.4
PA3782 Probable transcriptional regulator 2.1 (0.3) ------ 0.5 1.1
pilB (PA4526) Type 4 fimbrial biogenesis protein 2.8 (0.7) ------ 4.5 2.3
pilC (PA4527) Type 4 fimbrial biogenesis protein 6.5 (3.7) -------- 3.1 2.1
pilY1 (PA4554) Type 4 fimbrial biogenesis protein 4.5 (0.7) ------ 4.1 1.7
sadB (PA5346) Predicted signal transduction protein 2.7 (0.5) ------ 0.9 1.3
lasI (PA1432) Autoinducer synthesis protein 0.4 (0.02) ------ 1.3 7.0
rhlA (PA3479) rhamnosyltransferase chain A 0.03 (0.01) ------ 3.0 1.1
rpoN (PA4462) RNA polymerase sigma-54 factor 2.1 (0.3) ------ 0.8 0.5
*Data was obtained from supplementary tables S4-S10 in Waite et al. (available at http://www.biomedcentral.com/content/supplementary/1471-2164-7-162-S3.xls) and
fold regulation was calculated by dividing LP signal with 8 h or dividing SP signal with 48 h biofilm signal or vice versa if expression was down-regulated.
doi:10.1371/journal.pone.0015131.t002
Figure 2. Microtiter Plate Biofilm Assay. P. aeruginosa wild-type strain PA14 and the listed mutants (obtained from a non-redundant PA14
transposon-insertion mutant library) were incubated in 96-well microtiter plates with different substrates (polystyrene and polypropylene) for 12–
14 hours at 37uC. Growth was measured by spectrophotometry (OD630). To assess biofilm formation, microtiter plates were then emptied, washed
with sterile 0.9% normal saline, incubated with 1% crystal violet for 15 minutes at RT, then destained with 95% ethanol. The results are the means of
three separate biological experiments. Each biological experiment contained 7 technical replicates; the mean was obtained for each biological
experiment. The red line indicates biofilm and growth rate for wild-type strain PA14 (100% WT).
doi:10.1371/journal.pone.0015131.g002
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aeruginosa GI colonization, mice were made neutropenic by
administering a single 200 mg injection of monoclonal antibody
RB6-8C5 [7,26]. One-hundred percent of mice colonized with
WT PA14 (n=8) were euthanized when moribund or died in
between observation periods. Seventy-five to 100% of mice
colonized with all 16 of the PA14 strains with transposon
insertions (n=8 for each mutant strain) in the genes needed for
full biofilm formation also became moribund and were euthanized
or died in between observation periods. Thus, there were no
significant differences in mortality in mice colonized with either
WT PA14 or Tn-mutant strains unable to produce biofilms in
vitro (Table 3).
To verify P. aeruginosa bacteremia and dissemination had
occurred in the moribund/dead animals, spleens from these
mice were resected and homogenized. Homogenates were
serially diluted and plated on both TSA and cetrimide agar.
The presence of green, oxidase-positive colonies on cetrimide
agar and absence of any heterogeneous colony types on TSA
agar confirmed the presence of P. aeruginosa. All deceased mice
had only P. aeruginosa recovered from the spleens, ranging in
levels from 10
6 to 10
9 C F U / gs p l e e n( F i g u r e5 ) .A sw i t ht h eT n -
mutant strains recovered from the feces, maintenance of the
mutant genotype following dissemination was also confirmed
with colony PCR performed on P. aeruginosa grown from spleen
homogenates.
Colonization and Dissemination of P. aeruginosa Type III
Secretion Mutants in the murine GI tract
Given that the uniform high expression levels of the genes
involved in T3SS detected during GI colonization, we investigated
the colonization and dissemination phenotypes of P. aeruginosa
strains wherein the exoS, exoT or popB genes were deleted in strains
PAO1 and PAK as well as the transposon insertional mutants in
T3SS genes including exoU in the PA14 background. All three
wild-type strains colonized the mouse GI tract at levels
comparable to those previously reported [7]: P. aeruginosa strain
PAK (n=8, median=1.35610
8 cfu/g stool, first quar-
tile=1.03610
8, third quartile=1.93610
8); strain PA14 (n=8,
median=5.60610
7 cfu/g stool, first quartile=2.85610
7, third
quartile=8.77610
7); and strain PAO1 (n=8, med-
ian=1.19610
8 cfu/g stool, first quartile=7.21610
7, third quar-
tile=1.35610
8). All T3SS mutant strains colonized the murine GI
tract at levels comparable to or even higher (in the PA14 mutants)
Figure 3. Biofilm/Growth Ratios for P. aeruginosa PA14 transposon-insertion mutants listed above. Bars represent the means for three
separate biological replicates (each biological replicate is the mean of seven technical replicates). Ratios ,1 indicate decreased biofilm formation
relative to growth level. By definition WT biofilm/growth ratio is 1, as biofilm and growth levels were used to calculate the ratio are in % of WT. The
red line indicates biofilm growth ratio of 1.0.
doi:10.1371/journal.pone.0015131.g003
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the T3SS does not appear to be critical for GI colonization.
After the mice were made neutropenic by administering mAb
RB6-8C5, 100% of mice colonized with WT strains PAK (n=8),
PA14 (n=8), or PAO1 (n=8) became moribund and were
euthanized or died between observation periods. In contrast, there
were significant differences in the length of survival between the
WT and all their isogenic T3SS mutant strains (Figure 6)
indicating that dissemination of P. aeruginosa in the setting of
neutropenia is modified by the T3SS. However, in these
experiments an overall mouse survival of #37.5% is not
statistically different from the 100% lack of survival following
dissemination of the WT parental strains, and while this was
observed for all of the T3SS mutants in strain PAO1, only the
mice infected with PAKDexoT strain had an overall significantly
higher survival in this strain background. While mice infected with
the PAK double DexoSDexoT mutant did not survive any better
than the mice infected with the parental PAK strain, the difference
in survival between mice infected with the single DexoT mutant
and double DexoSDexoT strains was only 1 animal, likely indicative
of normal experimental variation. None of the mice infected with
the PA14 T3SS-deficient strains had significantly greater overall
survival compared to survival of mice infected with the parental
PA14 strain.
Discussion
P. aeruginosa’s pathogenic signature revolves around its ability to
cause infectious in many clinical settings: ventilator-associated
pneumonia, chronic lung infections in CF patients, skin and soft
tissue infections of burn victims, and bacteremia and sepsis in
cancer patients. The pathogenesis of P. aeruginosa bacteremia in
cancer patients derives from a combination of a chronic, usually
non-pathogenic state of GI colonization followed by an acute,
invasive infection caused by extra-intestinal bacterial translocation
and subsequent bacteremia once the immune system is compro-
mised [9,10,27]. Using a murine model of P. aeruginosa GI
colonization and neutropenia-induced dissemination, we have
shown that factors critical for establishing disseminated disease in
this model encompass the ability to establish GI colonization at
quantitatively sufficient levels (e.g. a minimum of 10
7 cfu/g stool)
to allow for dissemination from the GI tract once neutropenia is
Figure 4. Gastrointestinal Colonization Levels Mice fed P. aeruginosa strains PA14 and the above listed PA14 transposon insertion
mutants. Points represent result from individual animals (female 6–8 wk-old C3H/HeN mice), and horizontal lines represent the medians. n=8 for
each strain. Colonization levels with strain Dcrc were significantly lower (p,0.05 by Kruskal Wallis with Dunn’s multiple comparison test) compared
with wild-type strain PA14 (WT).
doi:10.1371/journal.pone.0015131.g004
Analysis of P. aeruginosa Gene Expression In Vivo
PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e15131induced [7]. We hypothesized that a microarray analysis of in vivo
expressed mRNA transcripts during GI colonization would
identify genes and/or phenotypes predictive of essentiality for
the initiation and/or maintenance of the colonization state.
However, while increased transcription of genes involved in both
biofilm formation and T3SS were found during GI colonization,
mutations in genes needed for these phenotypes did not alter the
ability of P. aeruginosa to colonize the murine GI tract. We did find
that loss of T3SS factors significantly increased the length of
survival of mice infected with these mutants, but there was a
variable effect of loss of the T3SS on overall mouse lethality. In
general, our results indicate that increased mRNA transcription
during in vivo infection may not be indicative of the need for the
encoded protein in the infectious process.
We chose to use the PAK strain for these transcription profiling
experiments because we had the greatest experience using this
particular P. aeruginosa strain for microarray analysis[18], and at
the time of these initial experiments, the PA14 TN library was not
available. We only decided to utilize the PA14 TN mutants
subsequent to the initial transcription profiling experiments.
However, in retrospect the use of a different P. aeruginosa strain
background to validate the results with specific Tn mutants based
on transcriptome-findings with a heterologous strain probably
adds robustness to the data as strain-specific effects are less likely to
have been analyzed in the follow-up studies with the Tn mutants.
In addition to genes encoding proteins needed for biofilm
formation and T3SS, 40% of genes involved in Cell Wall/LPS/
Capsule production were generally increased by two-fold or more
over expression when the bacteria are in water. The ability of P.
aeruginosa to synthesize a complete LPS outer core [24] appears to
be critical for establishing GI colonization in this murine model
[7]. LPS and O-antigen synthesis have also been shown to be
critical in establishing GI colonization with Yersinia pseudotuberculosis
[28], Yersinia enterocolitica [29], and E. coli [30]. Thus, we did not
explore these phenotypes in more depth as the need for production
of an intact LPS by P. aeruginosa to establish and maintain GI
colonization has been validated.
Son et al. [6] reported on P. aeruginosa transcript expression in
CF sputum and found a limited number of transcripts expressed in
vivo compared to those expressed by the same P. aeruginosa strain
grown in vitro. This was surprising given the observation of specific
phenotypes of the organisms found in vivo, such as elaboration of
alginate, not correlating with increased transcription of synthetic
or regulatory genes known to affect this phenotype. Further
analysis indicated that the clinical isolate had increased constitu-
tive expression of mRNA transcripts when grown in vitro when
compared to the mRNA expression in the sequenced PA01 strain,
indicating that many of the phenotypes that had emerged during
chronic infection were based on genetic changes that were not
markedly affected by transfer to the in vitro state for bacterial
growth. When these findings are factored into our results, it seems
that a quantitative increases in vivo expression of P. aeruginosa
mRNA transcripts over that of a comparator in vitro state may have
a limited role in predicting genes involved in the overall
pathogenesis process.
In our experimental data set we found that 90% of the genes
involved in T3SS had increased expression levels compared with
P. aeruginosa in water, and in fact, almost 50% of these genes had
expression levels .10-fold compared to baseline (Table 1) and
none had decreased expression compared to baseline levels.
However, this increased transcription of the T3SS genes did not
predict a role in GI colonization but was associated with increases
in the time of mouse survival following dissemination after
induction of neutropenia. This suggests an importance of these
effectors in the pathogenic process directed to bacterial translo-
cation out of the GI tract and the associated ability of the T3SS
effectors to systemically intoxicate host cells and tissues. Of note,
there was not a uniform effect on overall survival in all three P.
aeruginosa strains resulting from a loss of T3SS. With strain PAO1
all of the groups of mice infected with T3SS mutants had increased
survival, whereas with strain PAK the group of mice infected with
the DexoT mutant, but not the mice infected with the DexoS or
double DexoS/DexoT, survived better than the parental group.
With strain PA14 none of the mice infected with the T3SS
mutants had better overall survival than mice infected with the
parental strain. In the setting of experimental lung infection in
animals evaluating the ExoU cytotoxin [31] as well as data from
human P. aeruginosa lung infections [32,33,34] there is an
indication of a role of the T3SS in virulence, although deletion
of individual T3SS effectors in strain PAO1 had little effect on
overall bacterial replication and survival in the lung [35], and only
popB- and exoSTY-deleted mutants had a defect in systemic spread
from the lung. All of these findings, including those reported here,
not only emphasize the effect of strain background on the
properties of mutant phenotypes but also raise questions as to the
degree to which the T3SS is a factor in P. aeruginosa virulence
among clinical isolates and in which settings of infection this
virulence factor is essential.
In work previously reported by this laboratory, we demonstrat-
ed using immunohistochemical examination of intestinal tissues
(cecal) obtained from mice colonized with P. aeruginosa that clumps
of bacteria were trapped within the mucus layer of the murine
cecums, while few bacterial cells were associated with the
underlying epithelial cells[36]. Thus it appears that P. aeruginosa
is embedded in an extracellular matrix in vivo, reminiscent of the
phenotype commonly referred to as a biofilm mode of growth
[37]. Consistent with these observations are results from
histochemical staining and electron microscopy of lung tissue
specimens obtained at autopsy from cystic fibrosis patients that
Table 3. Survival of neutropenic mice after administration of
0.2 mg RB6-8C5 MAb i.p.
Colonizing Strain
of P. aeruginosa
No. of survivors/No.
challenged mice
Wildtype PA14 0/8
PA14crc- 0/8
PA14fleR- 0/8
PA14flgK- 1/8
PA14fliP- 0/8
PA14pilB- 0/8
PA14pilC- 2/8
PA14pilY1- 1/8
PA14sadB- 0/8
PA14PA0141- 2/8
PA14PA0713- 0/8
PA14PA0952- 1/8
PA14PA1009- 0/8
PA14PA3782- 2/8
PA14lasI- 0/8
PA14rhlA- 0/8
PA14rpoN- 1/8
doi:10.1371/journal.pone.0015131.t003
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and, like the cells seen in the murine GI tract, are associated with
the mucus and sequestered away from the epithelial surfaces of the
airways [38]. Therefore, there appears to be direct evidence
indicating that P. aeruginosa forms biofilms in both the GI and
respiratory tracts within the mucus layer, but our results indicate
that genes identified as being needed for P. aeruginosa biofilm
formation in vitro are not needed for the mode of growth of the
aggregated bacterial cells observed in vivo.
To fully test whether the biofilm-related genes that had
increased expression in vivo GI colonization were strong candidates
for further evaluation, we compared our microarray results with
those from published studies analyzing the in vitro transcriptomes of
P. aeruginosa cells growing in a biofilm to try and obtain a
comprehensive identification of genes with increased transcription
during biofilm growth. This was predicated on the lack of a
consensus from multiple in vitro studies identifying a clear set of
factors contributing to the biofilm phenotype, as this phenotype
itself can be generated by different in vitro conditions. When
comparing the GI colonization transcriptome data with previously
published studies of in vitro P. aeruginosa biofilm formation, we
ended up choosing twelve P. aeruginosa strains with interruptions in
genes related to biofilm production for full in vivo analysis (crc, fleR,
flgK, fliP, PA3782, pilB, pilC, pilY1, sadB, lasI, rhlA, and rpoN) even
though only 6 of these genes were found to have mRNA
transcripts increased by two-fold or more in vivo: flgK, PA3782,
pilB, pilC, pilY1, and sadB. Of note, all of the genes encoding
hypothetical proteins associated with in vitro biofilm production
showed expression levels that were increased by two-fold or more
in vivo, ranging from 4.4 to 24.8 fold increases from baseline
(Table 2). Nonetheless, even by expanding our in vivo analysis to
include evaluation of the need for genes found to be involved in in
vitro biofilm formation that did not have increased expression in
vivo, we still could not validate a role for biofilm formation in P.
aeruginosa colonization of the GI tract and dissemination following
induction of neutropenia.
Most of the biofilm-defective strains chosen for in vivo analysis
showed this phenotype in vitro. We chose to utilize two different
types of plastic to detect biofilm formation, PS and PP, since prior
investigators had shown that some mutations resulted in loss of
biofilm formation only on specific substrates, [20]. We found that
with the exception of PA14DrhlA, which formed WT-levels of
biofilms on both PS and PP, all the remaining mutant strains were
attenuated in biofilm formation on both substrates (Fig. 2). Even
Figure 5. Viable counts of P. aeruginosa strains PA14 and PA14 Tn-mutants recovered from murine spleens. Points represent result from
individual animals (female 6–8 wk-old C3H/HeN mice), and horizontal lines represent the medians. n=6–8 for each strain (please refer to Table 3 for
actual numbers for each mutant strain). Mice were initially colonized with PA14 and then subsequently made neutropenic with monoclonal antibody
RB6-8C5 (0.200 mg IP once). Tn, transposon-insertion.
doi:10.1371/journal.pone.0015131.g005
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strains continued to show attenuated biofilm formation; the
exceptions that showed WT biofilm formation with the correction
for slower growth were the rhlA mutant on PS and the pilC mutant
on PP (Fig. 3). What was most striking, however, was that the galU
strain that we include as a negative control for murine GI
colonization had a significantly increased ability to form biofilms in
vitro, with a growth rate comparable to WT P. aeruginosa PA14
(Fig. 3). However, one of the limitations of the biofilm microtiter
assay is that it is an endpoint assay and provides no information
about biofilm developmental stages such as those that can be
analyzed in flow cells. Nonetheless, we tested mutants with
interruptions in both the sadB [19] and lasI [39] genes that have
been shown to affect biofilm formation in dynamic flow cell assays
and found they were also not attenuated in our in vivo system.
While it is not clear which in vitro assay, if any, is useful for
identifying strains attenuated for biofilm formation in vivo, which in
and of itself is not a defined entity, our results suggest that the most
commonly used in vitro methods do not reliably identify genes
needed for in vivo virulence.
Only one P. aeruginosa PA14 mutant, the Dcrc strain exhibited a
defect in GI colonization, which was nearly ten-fold lower than the
wild-type strain (Fig. 4). While it is unclear if differences in
colonization levels are physiologically significant, especially since
the crc mutant caused comparable mortality to that of the WT
PA14 following induction of neutropenia, it is conceivable that in a
murine host colonized with P. aeruginosa along with other
indigenous microbial cells, including anaerobic species, that a
one log decrease in colonization rate may prevent disseminated
disease from developing. We have found that a certain threshold
Figure 6. Survival curves of neutropenic mice colonized with wild-type P. aeruginosa and T3SS mutant strains. Female 6–8 wk-old C3H/
HeN mice were colonized with P. aeruginosa strains PAO1(A), PAK (B), and PA14 (C) and with various deletional or insertional mutations of the type III
secretion system in the corresponding WT background and then subsequently made neutropenic with monocloncal antibody RB6-8C5 (0.200 mg IP
once). Median survival of mice colonized with mutants was significantly higher than that of mice colonized with the corresponding wildtype strain
(P,0.009 for PAO1 mutants, P,0.009 for PAK mutants, P,0.006 for PA14 mutants, log-rank test). Each group contained 8 mice. T3SS, type III
secretion system.
doi:10.1371/journal.pone.0015131.g006
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7 cfu/g stool) is
needed in order for translocation to occur once neutropenia is
induced (AYK and GPB, unpublished observation).
In conclusion, we have utilized several independent molecular
and genetic approaches to investigate whether P. aeruginosa genes
noted to be important in in vitro biofilm formation exhibited any
specific phenotype in a murine model of GI colonization and
neutropenia-induced dissemination. Ultimately, we found that
attenuation of biofilm formation in a static in vitro microtiter well
did not correlate with a significant change in GI colonization
level or mortality secondary to disseminated disease. These
findings, however, do not completely diminish the importance of
biofilm formation by P. aeruginosa with regards to GI tract
colonization. Collections of microbial cells that could be called a
biofilm have previously been described in the mucus covering the
intestinal epithelial wall and on particulate matter in the intestine
[40,41]. It is possible that P. aeruginosa does not need any of its
own gene products to make a biofilm in vivo, as the mucus layer of
the intestine is believed to entrap microorganisms [42] and thus
may provide the environment needed for P. aeruginosa cells to
grow close together. If the microorganism can also survive the
antimicrobial factors excreted by the host [43] and can proliferate
faster than the mucus is being shed [44], then a microbial
reservoir is created [45]. The mucus layer could potentially act as
an entrapping matrix, similar to the exopolysaccharide (EPS)
matrix secreted by biofilm forming organisms [46]. Thus, while
all 16 genes in P. aeruginosa that were thought to be needed for
biofilm formation in vitro had no appreciable phenotype in vivo,
indicating that targeting these genes for disruption by therapeutic
interventions likely will have little effect of the pathogenesis on
infection and disease, there may still be potential interventions in
the mucosal colonization process that could reduce the ability of
P. aeruginosa to cause serious systemic infections. Similarly, we
found that while transcription levels of T3SS genes were
markedly elevated in the colonization state versus the basal state,
the phenotype observed was not of decreased GI colonization but
of decreased dissemination and yet there was also a variable effect
from loss of the T3SS when measuring overall survival of
neutropenic mice infected with mutant strains. Ultimately
microarray analysis of in vivo transcriptomes to define genes
needed for virulence may not be a particularly accurate tool and
it seems likely better methods and experimental designs will be
needed to obtain a more accurate prediction of virulence factors
that impact P. aeruginosa virulence.
Materials and Methods
Bacterial strains and growth
The strains of P. aeruginosa used are listed in Table 4. The
ordered transposon library in strain PA14 [13] was kindly
provided by Dr. Fred Ausubel, Boston, MA. P. aeruginosa strains
were grown overnight at 37uC in Luria Bertani (LB) broth (with
the addition of 0.015 mg gentamicin/mL for PA14 transposon-
insertion mutants), harvested by centrifugation, washed with PBS,
and resuspended in PBS in preparation for in vitro biofilm assays as
well as for inoculation into the drinking water to establish GI
colonization in mice. The P. aeruginosa concentration was estimated
using a spectrophotometer and actual cfu counts verified by
enumeration on LB and cetrimide agars.
Production or RB6-8C5 monoclonal antibody and
induction of neutropenia
The RB6-8C5 mAb specific for the Ly6 antigen that is highly
expressed by polymorphonuclear neutrophils (PMN) was pro-
duced by growth of hybridoma cells in culture (Dulbecco’s
modified Eagle’s medium with 10% fetal calf serum (FCS))
followed by purification of antibody by protein G chromatogra-
phy, as previously described [7]. A single dose of 200 mg of RB6-
8C5 was administered to C3H/HeN mice to produce a severe
neutropenia (absolute neutrophil count ,100) for 5 days [7].
Murine model of P. aeruginosa GI colonization and
neutropenia-induced dissemination
We used a murine model of P. aeruginosa GI colonization and
neutropenia-induced dissemination as previously described [7]
with minor modifications. Six- to 8-week-old female C3H/HeN
mice (Harlan Laboratories) were housed as groups of 4 in
sterilized cages equipped with filter hoods. Mice were supplied
with sterile bedding, sterile water and sterile mouse chow and
maintained under specific pathogen-free conditions at the animal
facilities of the Harvard Medical School in compliance with the
Harvard Medical Area Institutional Animal Care and Use
Committee guidelines and at the animal facilities of the
University of Texas Southwestern Medical Center in compliance
with the Institutional Animal Care and Use Committees of the
University of Texas Southwestern Medical Center. To deplete
the indigenous GI bacterial flora, mice were fed sterile water with
2 mg streptomycin/mL (Research Product International, Mt.
Prospect, IL) and 1500 U penicillin G/mL (Sigma-Aldrich, St.
Louis, MO) for 4 days. Stool was collected from individual mice
(0.030–0.050 g per stool pellet), homogenized in 1 mL 1%
proteose peptone, and 100 ml of the homogenate was spread on
trypticase soy (TSA) and MacConkey agars and grown overnight
at 37uC to verify reduction of indigenous GI microbial flora. P.
aeruginosa strains were grown as described above, added to sterile
water with 1500 Units penicillin G/mL at approximately
10
7 cfu/ml, and then administered to mice for 5 days. Bacterial
water was changed every second day to maintain adequate cfu
levels. After 5 days of exposure to P. aeruginosa, stool was again
collected, homogenized in 1 mL 1% protease peptone, serially
diluted in 1% proteose peptone and dilutions plated on TSA and
LB agar (with 0.015 mg gentamicin/mL (Research Product
International, Mt. Prospect, IL) for PA14 transposon insertion
mutants) to measure levels of GI colonization by P. aeruginosa.
Once colonization with P. aeruginosa was confirmed, 200 mgo f
mAb RB6-8C5 was administered to each mouse by IP injection.
For mice colonized with PA14 transposon insertion mutants,
sterile water with 1500 Units penicillin G/mL and 0.015 mg
gentamicin/mL was initiated after RB6-8C5 administration.
Mice were monitored for morbidity for 7 days. Moribund mice
were euthanized and along with mice found dead between
observation periods, the carcasses were frozen at minus 20uC,
later thawed, spleens were resected, homogenized in 1 mL 1%
protease peptone, serially diluted and 10 ml of the homogenate
was drip-plated on TSA and LB (with or without 0.015 mg
gentamicin/mL) agar plates. Growth media were incubated at
37uC overnight under aerobic conditions. The presence of green
oxidase-positive colonies was used for confirmation of P. aeruginosa
systemic dissemination.
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Harvard Medical Area Institutional
Animal Care and Use Committee (Permit Number: 404-R98) and
the Institutional Animal Care and Use Committees of the
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Number: 2009-0243). All efforts were made to minimize suffering.
RNA Isolation
In order to establish a comparative transcriptome for P.
aeruginosa isolated from colonized mice, we isolated P. aeruginosa
RNA from bacteria in the drinking water provided to the mice.
Sterile water with 1500 Units penicillin G/mL and P. aeruginosa
strain PAK (10
7 cfu/ml) was stored in a sterile flask for 24 hours.
Bacteria were harvested by centrifugation, and the RNA isolation
protocol described below was initiated.
To obtain transcriptome information from bacteria colonizing
the murine GI tract, we initiated the murine model utilizing the P.
aeruginosa PAK strain. Seven days after initiating P. aeruginosa
drinking water and two days after confirmation of GI colonization
with PAK, eight mice were euthanized and the cecal contents were
flushed with a buffer containing 10 mM TrisHCl, 1 mM EDTA
and 200 mM NaCl [47] into a sterile stainless steel mortar (Fisher
Scientific, Pittsburgh, PA) which was immediately immersed in
liquid nitrogen. Cecal flushate contents were then ground with a
sterile pestle on a stainless steel mortar immersed in liquid
nitrogen, then added to 0.5 volume of boiling lysis buffer (2%
SDS, 16 mM EDTA, 200 mM NaCl), homogenized, and kept at
100uC for 5 minutes with frequent mixing. A hot acid
phenol:chloroform(5:1 ratio of phenol:chloroform, Ambion, Foster
City, CA) extraction was carried out at 65uC. An additional 2–3
room temperature acid phenol:chloroform extractions were
performed [48] followed by a final chloroform:isoamyl alcohol
extraction. Isopropanol (Sigma-Aldrich, St. Louis, MO) precipi-
tation at 220uC, overnight was followed by treatment with RQ1
DNase (Promega Corporation Madison, WI) for 1 hour at 37uCt o
remove contaminating DNA. After DNase treatment and
additional cold acid phenol:chloroform extractions, a final
chloroform:isoamyl alcohol extraction was performed. The
Table 4. Bacterial strains and genotype used in this study.
Strain Relevant genotype or description Source or reference
PAO1 Wildtype, serotype O2/O5, noncytotoxic, chloramphenicol sensitive, pilC
+ M. Vasil
PAO1DexoS PAO1DexoS [35]
PAO1DexoT PAO1DexoT [35]
PAO1D2TOX PAO1DexoSDexoT [35]
PAO1D3TOX PAO1DexoSDexoTDexoY [35]
PAO1DpopB PAO1DpopB [35]
PAK Wildtype S. Lory
PAKDexoS PAKDexoS S. Lory
PAKDexoT PAKDexoT S. Lory
PAKD2TOX PAKDexoSDexoT S. Lory
PA14 Wildtype, serogroup O10 strain, cytotoxic (ExoU
+)[ 5 0 ]
PA14crc- crc::MAR2xT7
a (Gm
R,1 5mg/ml) [13]
PA14fleR- fleR::MAR2xT7 (Gm
R,1 5mg/ml) [13]
PA14flgK- flgK::MAR2xT7 (Gm
R,1 5mg/ml) [13]
PA14fliP- fliP::MAR2xT7 (Gm
R,1 5mg/ml) [13]
PA14galU- galU::MAR2xT7 (Gm
R,1 5mg/ml) [13]
PA14pilB- pilB::MAR2xT7 (Gm
R,1 5mg/ml) [13]
PA14pilC- pilC::MAR2xT7 (Gm
R,1 5mg/ml) [13]
PA14pilY1- pilY1::MAR2xT7 (Gm
R,1 5mg/ml) [13]
PA14sadB- sadB::MAR2xT7 (Gm
R,1 5mg/ml) [13]
PA14PA3782- PA3782::MAR2xT7 (Gm
R,1 5mg/ml) [13]
PA14PA0141- PA0141::MAR2xT7 (Gm
R,1 5mg/ml) [13]
PA14PA0713- PA0713::MAR2xT7 (Gm
R,1 5mg/ml) [13]
PA14PA0952- PA0952::MAR2xT7 (Gm
R,1 5mg/ml) [13]
PA14PA1009- PA1009::MAR2xT7 (Gm
R,1 5mg/ml) [13]
PA14lasI- lasI::MAR2xT7 (Gm
R,1 5mg/ml) [13]
PA14rhlA- rhlA::MAR2xT7 (Gm
R,1 5mg/ml) [13]
PA14rpoN- rpoN::MAR2xT7 (gm
R,1 5mg/ml) [13]
PA14exoU- exoU::MAR2xT7 (gm
R,1 5mg/ml) [13]
PA14exoT- exoT::MAR2xT7 (gm
R,1 5mg/ml) [13]
PA14popB- popB::MAR2xT7 (gm
R,1 5mg/ml) [13]
aMAR2xT7 is a Himar1-derivative that originates from the eukaryotic mariner transposon-family [13].
Gm
R: Gentamicin resistance.
doi:10.1371/journal.pone.0015131.t004
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ethanol and 0.1 volume of 3 M sodium acetate (pH 5.5) at 280uC
for 30 minutes. RNA was further purified with RNeasy Mini RNA
purification kit (RNA cleanup protocol; Qiagen, Valencia, CA).
Samples were eluted in 60 ul of RNase-free water. Purity was
confirmed by agarose gel electrophoresis and spectrophotometry
(Nanodrop Technologies, Wilmington, DE). No evidence of
eukaryotic rRNA (18 s at 1.9 kb and 28 s at 5 kb) was detected
using Northern analysis of ethidium bromide stained gels. All
RNA samples used for cDNA synthesis had 260/280 ratios
ranging from 1.7 to 2.0.
cDNA Synthesis and Microarray Hybridization
cDNA was synthesized and hybridized to micoarray chips as
previously described [18]. The protocol and modifications were
as follows: 12 micrograms of purified total RNA extracted from
pooled murine cecal samples (8 mice) or the drinking water
containing strain PAK were converted to cDNA with Super-
script II Reverse transcriptase (Invitrogen, Carlsbad, CA) and a
semi-random decamer, termed (NS)5 (Invitrogen Life Technol-
ogies, custom oligonucleotide order, 59NSNSNSNSNS 39,
where N=A,T,C, or G and S=C or G). As a control for
cDNA production and microarray hybridization, control RNAs
were spiked into the reverse transcriptase reaction. The
resulting cDNA was purified, partially digested with DNase I,
and end labeled with ddUTP-biotin (Enzo Life Sciences,
Farmingdale, NY). The resulting targets were hybridized to
GeneChip P. aeruginosa Genome Arrays (Affymetrix,). Labeled
DNA was hybridized to Affymetrix P. aeruginosa Genome Arrays,
a n dc h i p sw e r ew a s h e d ,s t a i n e da n ds c a n n e da sp r e v i o u s l y
described [18].
Microarray Analysis and Statistical Significance
Assessment
Hybridization intensity data was collected from the scanned
array images of three replicate experiments (for both baseline and
GI colonization transcriptome levels), and intrachip normaliza-
tions were performed with Affymetrix Microarray Suite 5.0
software. Statistical analysis and experimental comparisons were
made with GeneSpring version 4.2.1 (Agilent Technologies, Santa
Clara, CA). Significance was established on the basis of three
criteria: first, a Welch t-test was performed to determine whether
the difference in expression for a given gene was greater between
test conditions than within replicates of the same condition. For
this test, a probability cutoff of 0.1 was used (p,0.1). Next, the
average hybridization intensity for each probe set had to be above
background in the activating condition. This determination was
made on the basis of the default absolute call metric in Microarray
Suite 5.0 (Affymetrix). Third, the magnitude of change between
two conditions (baseline drinking water and GI colonization state)
had to be greater than 2-fold [18]. Data generated from three
separate microarrays were used to calculate average transcription
levels. All microarray data is MIAME compliant and has been
deposited into the Gene Expression Omnibus database (accession
number GSE22665).
Colony PCR and gel electrophoresis
A singlecolony wasselectedfrom aplate, transferredinto30 ml
ddH2Oa n db o i l e da t1 0 0 uC for 5 min. Cell debris was pelleted
by centrifugation (2 min at 16,0006g), and supernatants
transferred into a new tube and stored on ice. The supernatant
was used as DNA template for the PCR reaction, which
contained 43 ml of the PCR Platinum Supermix (Invitrogen,
C a r l s b a d ,C A ) ,1ml of each forward and reverse primer (10 mM)
and 5 ml of DNA template combined in a PCR tube. Forward
and reverse primers are listed in Table S1. PCR conditions were
as follows: 94uC for 30 sec; 30 cycles of 94uC for 30 sec, 55uCf o r
30 sec and 72uC for 1 min.; final ext. at 72uCf o r5m i n .F o rg e l
electrophoresis, 1% agarose (American Bioanalytical, USA) in
T A Eg e lw a su s e d .S a m p l e sw e r er u na t1 0 0Vf o r8 0m i na n d
examined in a BioRad Gel Doc XR system (Biorad Laboratories,
Hercules, CA).
All 20 of the mutants used that were retrieved from the P.
aeruginosa PA14 transposon library (24) were confirmed to have the
correct insert based on the results from the colony PCR. The crc
mutant produced a blue/green phenotype when growing on LB-
agar, similar to what was observed by others [22,49].
Microtiter plate biofilm assay
The in vitro biofilm assay was performed as previously described
[20] with the following modifications. A P. aeruginosa Tn-mutant
strain of interest was grown overnight at 37uC on LB agar plates,
then suspended in sterile water with 1500 U Penicillin G/mL and
0.015 mg gentamicin/mL to a concentration of 10
9 CFU/ml. No
antibiotics were added for wild-type strains. P. aeruginosa bacterial
suspensions were serially diluted to a final concentration of 1:100;
100 ml was transferred to seven replicate wells using sterile PS 96-
well plates (Costar 3596, Corning, Corning, NY) or PP 96-well
plates (Costar 3364, Corning). Four wells in each plate were not
inoculated (LB medium only) for negative control references.
Plates were sealed with parafilm and incubated for 12–14 hours at
37uC. Growth was quantified by using a 96-well ELISA reader
and a wavelength of 630 nm (OD630) (ELx800, Bio-tek Instru-
ments, Winooski, VT). Microtiter plate wells were emptied and
washed twice in 130 ml 0.9% sterile NaCl. 200 ml 1% crystal violet
was added to each well and incubated for 15 min at RT. Wells
were then emptied, washed twice in 130 ml sterile 0.9% NaCl and
destained with 200 ml 95% ethanol for 5 min. Biofilm formation
was quantified using a 96-well ELISA Plate reader and an OD595
wavelength.
For in vitro biofilm formation under anaerobic conditions, we
utilized the same protocol as described above with the following
exceptions. P. aeruginosa strains were suspended in LB broth (with
or without gentamicin) containing 15 mM KNO3 at pH 6.5 and
grown anaerobically in a Coy anaerobic chamber at 37uC for
24 hours [3].
Statistical Analyses
Survival data were analyzed by Fisher’s exact test and log rank
test, and two-way comparisons of GI colonization levels were
carried out using the Kruskal-Wallis with Dunn’s multiple
comparison test to a single control group using the GraphPad
Prism software (San Diego, CA). When multiple comparisons or
more than two groups were analyzed, Bonferroni’s correction to
the significance level a was invoked.
Supporting Information
Table S1 Primer Names and sequences.
(DOC)
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